Common use of Maximum Deductions Clause in Contracts

Maximum Deductions. Notwithstanding Sections 5.5.1, 5.5.2 and 5.5.3 to the contrary, under no circumstances shall the reductions set forth in this Section 5.5 cause (a) the total Royalties payable to Pfizer in any Calendar Quarter to be reduced by more than [***] of the amount that would otherwise be due without giving effect to this Section 5.5, or (b) the Marginal Royalty Rates used to calculate Royalties in any Calendar Quarter to be reduced by more than [***] of the rates set forth in Section 5.4 (i.e., [***], [***], [***], [***] and [***], respectively).

Appears in 2 contracts

Sources: License Agreement (SpringWorks Therapeutics, Inc.), License Agreement

Maximum Deductions. Notwithstanding anything in Sections 5.5.16.5.1, 5.5.2 and 5.5.3 6.5.2 or 6.5.3 to the contrary, under no circumstances shall the reductions set forth in this Section 5.5 6.5 cause (a) the total Royalties payable to Pfizer in any Calendar Quarter to be reduced by more than [***] of the amount that would otherwise be due without giving effect to this Section 5.56.5, or (b) the Marginal Royalty Rates used to calculate Royalties in any Calendar Quarter to be reduced by more than [***] of the rates set forth in Section 5.4 (i.e., 6.4. [***], [***], [***], [***] and [***], respectively).

Appears in 1 contract

Sources: License Agreement (ARYA Sciences Acquisition Corp II)

Maximum Deductions. Notwithstanding Sections 5.5.1, 5.5.2 and 5.5.3 to the contrary, under no circumstances shall the reductions set forth in this Section 5.5 cause (a) the total Royalties payable to Pfizer in any Calendar Quarter to be reduced by more than [***] ([***]%) of the amount that would otherwise be due without giving effect to this Section 5.5, or (b) the Marginal Royalty Rates used to calculate Royalties in any Calendar Quarter to be reduced by more than [***] ([***]%) of the rates set forth in Section 5.4 (i.e., [***]%, [***]%, [***]%, [***] ]% and [***]%, respectively).

Appears in 1 contract

Sources: License Agreement (SpringWorks Therapeutics, Inc.)